Screening for Coronary Disease in Diabetes: When and How

Abstract

IN BRIEF

Coronary atherosclerosis and silent ischemia are highly prevalent in patients with diabetes. Identification of subclinical atherosclerosis and ischemia in asymptomatic patients with diabetes is valuable for risk stratification and for guiding therapy. This article reviews methods of screening and proposes how to implement them in practice.

Footnotes

  • Yasmine S. Ali, MD, is a fellow in cardiovascular medicine, and David J. Maron, MD, is an associate professor of medicine in the Division of Cardiovascular Medicine at Vanderbilt University Medical Center in Nashville, Tenn.

  • Note of disclosure: Dr. Maron is an employee of and stockholder in Cardiovascular Services of America, which provides outpatient cardiac catheterization and computed tomography angiography services.

« Previous | Next Article »Table of Contents